Perceptive Advisors as of March 31, 2023
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 99 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 9.1 | $307M | 28M | 11.09 | |
| Reata Pharmaceuticals Cl A | 5.8 | $197M | 2.2M | 90.92 | |
| Amylyx Pharmaceuticals (AMLX) | 5.2 | $177M | 6.0M | 29.34 | |
| Cerevel Therapeutics Hldng I (CERE) | 4.7 | $159M | 6.5M | 24.39 | |
| Madrigal Pharmaceuticals (MDGL) | 4.7 | $158M | 651k | 242.26 | |
| Prometheus Biosciences | 4.0 | $137M | 1.3M | 107.32 | |
| Arcellx Common Stock (ACLX) | 3.5 | $118M | 3.8M | 30.81 | |
| Lianbio Sponsored Ads (LIANY) | 3.3 | $113M | 58M | 1.96 | |
| Aldeyra Therapeutics (ALDX) | 3.3 | $113M | 11M | 9.93 | |
| Iovance Biotherapeutics (IOVA) | 2.8 | $94M | 15M | 6.11 | |
| Inhibrx | 2.0 | $68M | 3.6M | 18.87 | |
| Xenon Pharmaceuticals (XENE) | 1.9 | $66M | 1.8M | 35.79 | |
| BioMarin Pharmaceutical (BMRN) | 1.9 | $65M | 673k | 97.24 | |
| Treace Med Concepts (TMCI) | 1.8 | $62M | 2.4M | 25.19 | |
| Nuvalent Inc-a (NUVL) | 1.8 | $60M | 2.3M | 26.09 | |
| Mirati Therapeutics | 1.7 | $59M | 1.6M | 37.18 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.7 | $57M | 3.6M | 16.06 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.6 | $55M | 2.7M | 20.08 | |
| Springworks Therapeutics (SWTX) | 1.6 | $54M | 2.1M | 25.74 | |
| Health Sciences Acq Corp 2 (OBIO) | 1.3 | $45M | 2.3M | 19.57 | |
| Miragen Therapeutics (VRDN) | 1.3 | $44M | 1.7M | 25.44 | |
| Vaxcyte (PCVX) | 1.3 | $44M | 1.2M | 37.48 | |
| Rapt Therapeutics | 1.2 | $42M | 2.3M | 18.35 | |
| Sanofi Sponsored Adr (SNY) | 1.2 | $42M | 768k | 54.42 | |
| Adma Biologics (ADMA) | 1.2 | $39M | 12M | 3.31 | |
| Natera (NTRA) | 1.2 | $39M | 707k | 55.52 | |
| Acrivon Therapeutics Common Stock (ACRV) | 1.1 | $38M | 3.0M | 12.69 | |
| Apellis Pharmaceuticals (APLS) | 1.1 | $37M | 555k | 65.96 | |
| Meiragtx Holdings (MGTX) | 1.1 | $36M | 7.0M | 5.17 | |
| Sarepta Therapeutics (SRPT) | 1.1 | $36M | 261k | 137.83 | |
| Bellus Health Com New | 1.1 | $36M | 5.0M | 7.20 | |
| Cymabay Therapeutics | 1.0 | $34M | 3.9M | 8.72 | |
| Verrica Pharmaceuticals | 1.0 | $33M | 5.0M | 6.50 | |
| Relay Therapeutics (RLAY) | 0.9 | $32M | 1.9M | 16.47 | |
| Establishment Labs Holdings Ord (ESTA) | 0.9 | $32M | 468k | 67.74 | |
| Bridgebio Pharma (BBIO) | 0.9 | $32M | 1.9M | 16.58 | |
| Zymeworks Del (ZYME) | 0.9 | $31M | 3.4M | 9.04 | |
| Astria Therapeutics (ATXS) | 0.9 | $29M | 2.2M | 13.30 | |
| Nautilus Biotechnology (NAUT) | 0.7 | $25M | 9.1M | 2.77 | |
| Cogent Biosciences (COGT) | 0.7 | $25M | 2.3M | 10.79 | |
| Immatics SHS (IMTX) | 0.7 | $24M | 3.5M | 6.90 | |
| Protagonist Therapeutics (PTGX) | 0.7 | $22M | 965k | 23.00 | |
| Outset Med | 0.6 | $20M | 1.1M | 18.40 | |
| Immunovant (IMVT) | 0.6 | $20M | 1.3M | 15.51 | |
| Akero Therapeutics (AKRO) | 0.6 | $20M | 524k | 38.26 | |
| Roivant Sciences SHS (ROIV) | 0.6 | $20M | 2.7M | 7.38 | |
| Lyra Therapeutics | 0.5 | $18M | 9.1M | 2.01 | |
| Solid Biosciences Com New (SLDB) | 0.5 | $17M | 3.5M | 4.74 | |
| Tarsus Pharmaceuticals (TARS) | 0.5 | $16M | 1.3M | 12.57 | |
| Terns Pharmaceuticals (TERN) | 0.5 | $16M | 1.4M | 11.84 | |
| Vbi Vaccines Inc Cda Com New | 0.5 | $16M | 52M | 0.30 | |
| Rocket Pharmaceuticals (RCKT) | 0.4 | $15M | 868k | 17.13 | |
| Viking Therapeutics (VKTX) | 0.4 | $15M | 872k | 16.65 | |
| Mirum Pharmaceuticals (MIRM) | 0.4 | $14M | 602k | 24.02 | |
| Rain Therapeutics | 0.4 | $14M | 1.6M | 8.74 | |
| CryoLife (AORT) | 0.4 | $14M | 1.1M | 13.10 | |
| Axogen (AXGN) | 0.4 | $13M | 1.4M | 9.45 | |
| Intuitive Surgical Com New (ISRG) | 0.4 | $13M | 50k | 255.47 | |
| Iveric Bio | 0.4 | $12M | 500k | 24.33 | |
| Athira Pharma (ATHA) | 0.4 | $12M | 4.8M | 2.50 | |
| Cytek Biosciences (CTKB) | 0.3 | $12M | 1.3M | 9.19 | |
| Prothena Corp SHS (PRTA) | 0.3 | $12M | 238k | 48.47 | |
| Tactile Systems Technology, In (TCMD) | 0.3 | $11M | 640k | 16.42 | |
| Fusion Pharmaceuticals | 0.3 | $10M | 2.8M | 3.77 | |
| Larimar Therapeutics (LRMR) | 0.3 | $10M | 2.3M | 4.53 | |
| Neurocrine Biosciences (NBIX) | 0.3 | $10M | 100k | 101.22 | |
| Biomea Fusion (BMEA) | 0.3 | $10M | 325k | 31.01 | |
| Morphic Hldg (MORF) | 0.3 | $9.7M | 257k | 37.64 | |
| Caremax Com Cl A | 0.3 | $9.5M | 3.6M | 2.67 | |
| Tyra Biosciences (TYRA) | 0.2 | $7.9M | 494k | 16.07 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 0.2 | $7.6M | 100k | 76.21 | |
| Bellerophon Therapeutics Com New | 0.2 | $7.3M | 930k | 7.89 | |
| Hillevax | 0.2 | $6.7M | 406k | 16.53 | |
| Cabaletta Bio (CABA) | 0.2 | $6.0M | 725k | 8.27 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.2 | $5.4M | 590k | 9.16 | |
| Female Health (VERU) | 0.1 | $5.0M | 4.3M | 1.16 | |
| Landos Biopharma | 0.1 | $4.4M | 15M | 0.30 | |
| Singular Genomics Systems In | 0.1 | $4.0M | 3.3M | 1.21 | |
| X4 Pharmaceuticals | 0.1 | $4.0M | 4.5M | 0.87 | |
| Somalogic Class A Com | 0.1 | $3.8M | 1.5M | 2.55 | |
| Nanobiotix Sponsored Ads (NBTX) | 0.1 | $3.7M | 1.1M | 3.52 | |
| Envveno Medical (NVNO) | 0.1 | $3.7M | 782k | 4.68 | |
| Vir Biotechnology (VIR) | 0.1 | $3.3M | 142k | 23.27 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.1 | $3.3M | 100k | 32.65 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.1 | $2.9M | 1.5M | 1.95 | |
| Berkeley Lts | 0.1 | $2.9M | 2.5M | 1.16 | |
| Kronos Bio | 0.1 | $2.6M | 1.8M | 1.46 | |
| Leap Therapeutics | 0.1 | $2.3M | 6.7M | 0.34 | |
| Travere Therapeutics (TVTX) | 0.1 | $2.0M | 91k | 22.49 | |
| Quanterix Ord (QTRX) | 0.0 | $1.5M | 130k | 11.27 | |
| Dariohealth Corp Com New (DRIO) | 0.0 | $1.3M | 314k | 4.12 | |
| Clover Health Investments Com Cl A (CLOV) | 0.0 | $1.3M | 1.5M | 0.85 | |
| Athenex Com New (ATNXQ) | 0.0 | $1.0M | 777k | 1.33 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $908k | 290k | 3.13 | |
| Pear Therapeutics | 0.0 | $230k | 901k | 0.26 | |
| Motus Gi Hldgs Com New | 0.0 | $88k | 90k | 0.97 | |
| Eqrx *w Exp 12/17/202 | 0.0 | $43k | 250k | 0.17 | |
| Caremax *w Exp 06/08/202 | 0.0 | $29k | 60k | 0.48 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $17k | 167k | 0.10 |
